These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22798972)

  • 1. A Comprehensive Review of Clocortolone Pivalate 0.1% Cream: Structural Development, Formulation Characteristics, and Studies Supporting Treatment of Corticosteroid-responsive Dermatoses.
    Del Rosso JQ; Kircik L
    J Clin Aesthet Dermatol; 2012 Jul; 5(7):20-4. PubMed ID: 22798972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream.
    Kircik LH; Del Rosso JQ
    J Drugs Dermatol; 2012 Oct; 11(10):1194-8. PubMed ID: 23134984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of clocortolone pivalate for the treatment of corticosteroid-responsive skin disorders: a systematic review.
    Singh S; Mann BK
    Clin Cosmet Investig Dermatol; 2012; 5():61-8. PubMed ID: 22791998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolone pivalate 0.1% cream.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2014 Jul; 13(7):s77-83. PubMed ID: 25007376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of a midpotency topical corticosteroid and the clinical relevance of formulation characteristics in the management of commonly encountered eczematous and inflammatory dermatoses in adults and children: focus on the pharmacologic properties of clocortolone pivalate 0.1% cream.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2013 Feb; 12(2):s5-s10. PubMed ID: 23377405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clocortolone pivalate: a topical corticosteroid with a unique structure.
    Kircik LH
    J Drugs Dermatol; 2013 Feb; 12(2):s3-4. PubMed ID: 23377404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay.
    Kircik LH
    J Drugs Dermatol; 2014 May; 13(5):582-5. PubMed ID: 24809882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to clocortolone pivalate cream 0.1% in a pediatric population with atopic dermatitis.
    Conde JF; Kaur M; Fleischer AB; Tusa MG; Camacho F; Feldman SR
    Cutis; 2008 May; 81(5):435-41. PubMed ID: 18543596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative efficacy and interchangeability ofvarious clobetasol propionate vehicles in the management of steroid-responsive dermatoses.
    Feldman SR
    Curr Ther Res Clin Exp; 2005 May; 66(3):154-71. PubMed ID: 24672120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clocortolone pivalate cream 0.1% used concomitantly with tacrolimus ointment 0.1% in atopic dermatitis.
    Torok HM; Maas-Irslinger R; Slayton RM
    Cutis; 2003 Aug; 72(2):161-6. PubMed ID: 12953943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of clocortolone pivalate 0.1 percent cream in the treatment of atopic dermatitis, contact dermatitis, and seborrheic dermatitis.
    Nierman MM
    Cutis; 1981 Jun; 27(6):670-1. PubMed ID: 6453703
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of clobetasol propionate emollient 0.05% in the treatment of patients with dry, scaly, corticosteroid-responsive dermatoses.
    Gordon ML
    Clin Ther; 1998; 20(1):26-39. PubMed ID: 9522102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
    Wellington K; Jarvis B
    Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clobetasol propionate emollient formulation foam in the treatment of corticosteroid-responsive dermatoses.
    Frangos JE; Kimball AB
    Expert Opin Pharmacother; 2008 Aug; 9(11):2001-7. PubMed ID: 18627337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clocortolone pivalate: a paired comparison clinical trial of a new topical steroid in eczema/atopic dermatitis.
    Rosenthal AL
    Cutis; 1980 Jan; 25(1):96-8. PubMed ID: 6986236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the correlation between structure and dynamics of clocortolone pivalate by solid state NMR measurement.
    Dey KK; Gayen S; Ghosh M
    RSC Adv; 2020 Jan; 10(8):4310-4321. PubMed ID: 35495240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of skin concentrations following topical versus oral corticosteroid treatment: reconsidering the treatment of common inflammatory dermatoses.
    McClain RW; Yentzer BA; Feldman SR
    J Drugs Dermatol; 2009 Dec; 8(12):1076-9. PubMed ID: 20027934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spotlight on topical pimecrolimus in atopic dermatitis.
    Wellington K; Jarvis B
    Am J Clin Dermatol; 2002; 3(6):435-8. PubMed ID: 12113651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of atopic eczema.
    Werfel T; Claes C; Kulp W; Greiner W; von der Schulenburg JM
    GMS Health Technol Assess; 2006 Oct; 2():Doc19. PubMed ID: 21289970
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.